Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary lymphoproliferative disorders

G P Thompson1, J P Utz, E C Rosenow

  • 1Division of Thoracic Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Mayo Clinic Proceedings
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elective Localization and Focal Infection from Oral Sepsis.

The Dental register·2021
Same author

Frozen sections in patients undergoing breast conserving surgery at a single ambulatory surgical center: 5 year experience.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Benefits of pulsatile flow in pediatric cardiopulmonary bypass procedures: from conception to conduction.

Perfusion·2011
Same author

Hemodynamic evaluation of arterial and venous cannulae performance in a simulated neonatal extracorporeal life support circuit.

Perfusion·2011
Same author

The role of semantic knowledge in retrieval from episodic long-term memories: Implications for a model of retrieval.

Memory & cognition·2011
Same author

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

The European respiratory journal·2010
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles

This review classifies pulmonary lymphoproliferative disorders, detailing their clinical, radiographic, and pathologic features. It emphasizes diagnostic techniques and treatment responses for these complex lung conditions.

Area of Science:

  • Pulmonology
  • Pathology
  • Oncology

Background:

  • Pulmonary lymphoproliferative disorders encompass a wide range of lung conditions.
  • Advances in immunologic and molecular genetics have improved understanding.
  • Accurate diagnosis is crucial for effective management.

Purpose of the Study:

  • To classify pulmonary lymphoproliferative disorders into benign, intermediate, and malignant categories.
  • To describe the clinical, radiographic, and pathologic features of these disorders.
  • To highlight diagnostic approaches and treatment strategies.

Main Methods:

  • Literature review of pulmonary lymphoproliferative disorders.
  • Classification based on disease behavior (benign, intermediate, malignant).

Related Experiment Videos

  • Emphasis on clinical, radiographic, and histopathologic findings.

    • Main Results:

    • A comprehensive classification of pulmonary lymphoproliferative disorders is presented.
    • Detailed descriptions of clinical, radiographic, and pathologic characteristics are provided.
    • The role of tissue biopsy and ancillary diagnostic techniques is emphasized.

    Conclusions:

    • Accurate classification and diagnosis are essential for managing pulmonary lymphoproliferative disorders.
    • Integrated diagnostic approaches improve patient outcomes.
    • Understanding the full spectrum aids in selecting appropriate treatments.